Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunan Pharmaceutical Group is a leading integrated pharmaceutical conglomerate based in Linyi, Shandong, China. Established in 1968, the company has grown into a massive enterprise that develops, manufactures, and markets a wide range of healthcare products, including chemical drugs, modern Traditional Chinese Medicines (TCM), and innovative biologics. The group operates through several key subsidiaries such as Shandong New Time Pharmaceutical and Lunan Hope Pharmaceutical, focusing on therapeutic areas like oncology, cardiovascular health, and metabolic diseases. Lunan Pharma is recognized for its strong R&D capabilities, supported by national-level research centers, and maintains a significant presence in both the domestic Chinese market and international API supply chains. The company remains a private, collective enterprise with a workforce of over 15,000 employees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Lunan Chemical.